Categories
Herbs & Plants

Phyllanthous Amarus(Bhui Amla)

[amazon_link asins=’B00028MOUE,B00U3GY9EY,B01N4JMMTM,B01I1TK22W,3659676624′ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’b4743b41-5e20-11e7-ac6e-c5fb98a50c79′]

[amazon_link asins=’B00FEPUNUS,B005GGLPVQ,B00UYGJYUW,B01MR9Y9XH,B005GGNEDS,B005GGPWRE,B00UVFSQN2,B072JFJYRL’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’dcc75f78-5e1f-11e7-b450-131bccf1a816′]

Botanical Name: Phyllanthous Amarus
Family : Euphorbiaccac (Spurge family)./Phyllanthaceae

Kingdom: Plantae
Division: Magnoliophyta
Class: Magnoliopsida
Order: Malpighiales
Genus: Phyllanthus
Species: P. niruri
Common Name :Bahupatra ,Child pick-a-back, bhuiamla, gulf leafflower, black catnip, meniran, chanca piedra, shatterstone, stone breaker, quebra pedra, bahupatra, gale of wind, carry me seed, hsieh hsia chu.
Vernacular name : Kizharnelli.Kirganelli,Kizhkaynelli

Names in other Indian languages:-
Sanscrit : Bhumya malaki,Thamalaki
Hindi : Jar amla, Jangli amli
Bengali : Bhui amla, Sadhazur mani
Bihar : Mui koa. Kantara
Kannada : Nelanelli
Tamil : Kilanelli
Names in foreign languages:
Spanish : Yerba De Guinina
Franse : Herb Du Chagrin
Brazil : Erva, Pombinha
West Indies : Petit tamarin blanc
Habitat : Southern India,It is seen in Kerala commonly, in cultivated or waste places, especially in moist localities.It is a widespread tropical plant commonly found in coastal areas.

Description:
Shatterstone is a common annual weed in Suriname from the genus Phyllanthus that contains more than 700 species.

click to see the pictures…...(01)…….……….(1).……….(2)………….(3)…....………..
The plant grows up to no more than 1½ feet tall and has small yellow flowers and bears ascending herbaceous branches. The bark is smooth and light green. It bears numerous pale green flowers which are often flushed with red. The fruits are tiny, smooth capsules containing seeds.

YOU MAY CLICK TO SEE THE PICTURE (Phyllanthus niruri)
They have small leaves and very small (2mm) fruits that burst open and the seeds are hurled away.
When the plants are picked, the feathery leaves fold in, completely closing themselves.

The plant has long been used as an herbal remedy for urinary calculi, and has been shown in modern medical research studies to reduce the risks of stones in individuals prone to the condition. Research on the plant continues to determine if it has any other beneficial effects. It may have antiviral activity.

Shatterstone has antispasmodic – and liver protecting activity. Phyllantus Amarus and –Niruri also have anti-viral activity against chronic – and acute hepatitis-B.
Phyllanthus species are extensively used in Ayurvedic medicine.
Phyllanthus amarus, -niruri and closely related species; such as Phyllanthus urinaria, -debilis and -fraternus, seem to contain activity against the endogenous DNAp of hepadna – viruses.
They are all employed in the treatment against kidney – and gallstones as well, other kidney and liver related problems.
They are antihepatotoxic (liver protecting), antibacterial and hypoglycemic.
Other applications are against inflammation of the appendix, diabetes and for prostate problems.
An interesting aspect is the use of this plant for weight loss (slimming down).

Constituents:
Phyllanthus primarily contains lignans (e.g., phyllanthine and hypophyllanthine, 5-demethoxyniranthin, urinatetralin, dextrobursehernin, urinaligran), alkaloids (ent-norsecurinine, phyllanthoside) and flavonoids & tepenes (quercetin, quercetol, quercitrin), tannins.
Polyphenolic compounds (phyllanthusin F, methyl brevifolincarboxylate, trimethyl ester dehydrochebulic acid, n-octadecane, beta-sitosterol, ellagic acid, daucosterol, kaempferol, quercetin, gallic acid, rutin).

Empirical uses:-
The antiseptic, styptic, carminative, deobstruent, coolant, febrifugal, stomachic, astringent, and diuretic properties of this drug have been utilized in traditional medicine, since time immemorial. Its efficacy in the field of gastro intestinal disorders like dyspepsia, colic, diarrhoea, constipation,Aenimic, jaundice, Dropsy and dysentery is undisputed. In females it is used as a galactogogue, in leucorrhoea, menorrhagia and mammary abscess. In skin conditions, especially scabby or crusty lesions, bruises, wounds, scabies, offensive ulcers and sores, oedematous swellings, tubercular ulcers, and ringworm, it has been utilized with good effect since many years. It is applied effectively in intermittent fevers and gonorrhoea as well as in ophthalmia and conjunctivitis. It has a urolithic property, dissolving renal calculi. Also used in cough, asthma and other bronchial affections.

Clinical Studies:-
Clinical studies conducted with the extract of this plant, points to its great therapeutic efficacy, in the treatment of hepatitis B. Thyagarajan et a! in 1988 have done detailed clinical studies in this respect. In clinical trials, it has also been shown to be effective against infective hepatitis (hepatitis A). It’s antifungal, antiviral, and anticancerous properties have also been demonstrated in experimental animals. It is of great utility in the treatment of diabetes mellitus especially NIDDM as shown in clinical studies in Tanzania and elsewhere. The diuretic and hypotensive effects of this drug on human subjects have also been assessed by Srividya et al in 1995.

Click to see:->
Medicinal uses of Phyllanthus niruri, Phyllanthus urinaria, Phyllanthus amarus

Phyllanthus Amarus – Herb Cure for Hepatitis

Phyllanthus amarus, a world-renowned botanical, aids the liver

Tinctura Phyllanthus amarus & niruri

Disclaimer:The information presented herein is intended for educational purposes only. Individual results may vary, and before using any supplements, it is always advisable to consult with your own health care provider.

Resources:
http://www.globalherbalsupplies.com/herb_information/phyllanthus_amarus.htm
http://www.tropilab.com/black-cat.html
http://www.similima.com/proving2.html
http://en.wikipedia.org/wiki/Phyllanthus_niruri

Enhanced by Zemanta
Categories
Ailmemts & Remedies

Jaundice

Definition:
Jaundice, also known as icterus (attributive adjective: “icteric”), is yellowish discoloration of the skin, sclerae (whites of the eyes) and mucous membranes caused by hyperbilirubinemia (increased levels of bilirubin in the blood). This hyperbilirubinemia subsequently causes increased levels of bilirubin in the extracellular fluids. Typically, the concentration of bilirubin in the plasma must exceed 1.5 mg/dL, three times the usual value of approximately 0.5mg/dL, for the coloration to be easily visible. Jaundice comes from the French word jaune, meaning yellow.

CLICK & SEE THE PICTURES

Jaundice is not a disease but rather a sign that can occur in many different diseases. Jaundice is the yellowish staining of the skin and sclerae (the whites of the eyes) that is caused by high levels in blood of the chemical bilirubin. The color of the skin and sclerae vary depending on the level of bilirubin. When the bilirubin level is mildly elevated, they are yellowish. When the bilirubin level is high, they tend to be brown.

Normal Physiology
In order to understand how jaundice results, it is important to understand where the pathological processes that cause jaundice take their effect. It is also important to further recognize that jaundice itself is not a disease, but rather a symptom of an underlying pathological process that occurs at some point along the normal physiological pathway of the metabolism of bilirubin.

Pre-hepatic events
When red blood cells have completed their life span of approximately 120 days, or when they are damaged, their membranes become fragile and prone to rupture. As the cell traverses through the reticuloendothelial system, their cell membranes rupture and the contents of the red blood cell is released into the blood. The component of the red blood cell that is involved in jaundice is hemoglobin. The hemoglobin released into the blood is phagocytosed by macrophages, and split into its heme and globin portions. The globin portion, being protein, is degraded into amino acids and plays no further role in jaundice. Two reactions then take place to the heme molecule. The first reaction is the oxidation of heme to form biliverdin.This reaction is catalyzed by microsomal enzyme heme oxygenase and it results in biliverdin (green color pigment), iron and carbon monoxide. Next step is reduction of biliverdin to yellow color tetrapyrol pigment bilirubin by cytosolic enzyme biliverdin reductase. This bilirubin is known as “unconjugated”, “free” or “indirect” bilirubin. Approximately 4 mg per kg of bilirubin is produced each day. The majority of this bilirubin comes from the breakdown of heme from expired red blood cells in the process just described. However approximately 20 per cent comes from other heme sources, including ineffective erythropoiesis, breakdown of other heme-containing proteins, such as muscle myoglobin and cytochromes.

Hepatic events
The unconjugated bilirubin then travels to the liver through the bloodstream. Because this bilirubin is not soluble, however, it is transported through the blood bound to serum albumin. Once it arrives at the liver, it is conjugated with glucuronic acid (to form bilirubin diglucuronide, or just “conjugated bilirubin”) to become more water soluble. The reaction is catalyzed by the enzyme UDP-glucuronide transferase.

Post-hepatic events
This conjugated bilirubin is excreted from the liver into the biliary and cystic ducts as part of bile. Intestinal bacteria convert the bilirubin into urobilinogen. From here the urobilinogen can take two pathways. It can either be further converted into stercobilinogen, which is then oxidized to stercobilin and passed out in the faeces, or it can be reabsorbed by the intestinal cells, transported in the blood to the kidneys, and passed out in the urine as the oxidised product urobilin. Stercobilin and urobilin are the products responsible for the coloration of faeces and urine, respectively.

Symptoms:-
In jaundice, the skin and whites of the eyes appear yellow. Urine is often dark because excess bilirubin is excreted through the kidneys. People may have itching, light-colored stools, or other symptoms, depending on the cause of jaundice. For example, acute inflammation of the liver (acute hepatitis) may cause loss of appetite, nausea, vomiting, and fever. Blockage of bile may result in abdominal pain and fever.
Causes:

Bilirubin comes from red blood cells. When red blood cells get old, they are destroyed. Hemoglobin, the iron-containing chemical in red blood cells that carries oxygen, is released from the destroyed red blood cells after the iron it contains is removed. The chemical that remains in the blood after the iron is removed becomes bilirubin.

The liver has many functions. One of the liver’s functions is to produce and secrete bile into the intestines to help digest dietary fat. Another is to remove toxic chemicals or waste products from the blood, and bilirubin is a waste product. The liver removes bilirubin from the blood. After the bilirubin has entered the liver cells, the cells conjugate (attaching other chemicals, primarily glucuronic acid) to the bilirubin, and then secrete the bilirubin/glucuronic acid complex into bile. The complex that is secreted in bile is called conjugated bilirubin. The conjugated bilirubin is eliminated in the feces. (Bilirubin is what gives feces its brown color.) Conjugated bilirubin is distinguished from the bilirubin that is released from the red blood cells and not yet removed from the blood which is termed unconjugated bilirubin.

Jaundice occurs when there is 1) too much bilirubin being produced for the liver to remove from the blood. (For example, patients with hemolytic anemia have an abnormally rapid rate of destruction of their red blood cells that releases large amounts of bilirubin into the blood), 2) a defect in the liver that prevents bilirubin from being removed from the blood, converted to bilirubin/glucuronic acid (conjugated) or secreted in bile, or 3) blockage of the bile ducts that decreases the flow of bile and bilirubin from the liver into the intestines. (For example, the bile ducts can be blocked by cancers, gallstones, or inflammation of the bile ducts). The decreased conjugation, secretion, or flow of bile that can result in jaundice is referred to as cholestasis: however, cholestasis does not always result in jaundice.
When a pathological process interferes with the normal functioning of the metabolism and excretion of bilirubin just described, jaundice may be the result. Jaundice is classified into three categories, depending on which part of the physiological mechanism the pathology affects.

The three categories are:

*Pre-hepatic: The pathology is occurring prior the liver

*Hepatic: The pathology is located within the liver

*Post-Hepatic: The pathology is located after the conjugation of bilirubin in the liver

Pre-hepatic
Pre-hepatic jaundice is caused by anything which causes an increased rate of hemolysis (breakdown of red blood cells). In tropical countries, malaria can cause jaundice in this manner. Certain genetic diseases, such as sickle cell anemia, spherocytosis and glucose 6-phosphate dehydrogenase deficiency can lead to increased red cell lysis and therefore hemolytic jaundice. Commonly, diseases of the kidney, such as hemolytic uremic syndrome, can also lead to coloration. Defects in bilirubin metabolism also present as jaundice. Jaundice usually comes with high fevers.

Laboratory findings include:
*Urine: no bilirubin present, urobilirubin > 2 units (except in infants where gut flora has not developed).

*Serum: increased unconjugated bilirubin.

Hepatic
Hepatic jaundice causes include acute hepatitis, hepatotoxicity and alcoholic liver disease, whereby cell necrosis reduces the liver’s ability to metabolise and excrete bilirubin leading to a buildup in the blood. Less common causes include primary biliary cirrhosis, Gilbert’s syndrome (a genetic disorder of bilirubin metabolism which can result in mild jaundice, which is found in about 5% of the population), Crigler-Najjar syndrome, metastatic carcinoma and Niemann Pick Type C disease. Jaundice seen in the newborn, known as neonatal jaundice, is common, occurring in almost every newborn as hepatic machinery for the conjugation and excretion of bilirubin does not fully mature until approximately two weeks of age.

Laboratory Findings include:
Urine: Conjugated bilirubin present, Urobilirubin > 2 units but variable (Except in children)

Post-hepatic
Post-hepatic jaundice, also called obstructive jaundice, is caused by an interruption to the drainage of bile in the biliary system. The most common causes are gallstones in the common bile duct, and pancreatic cancer in the head of the pancreas. Also, a group of parasites known as “liver flukes” live in the common bile duct, causing obstructive jaundice. Other causes include strictures of the common bile duct, biliary atresia, ductal carcinoma, pancreatitis and pancreatic pseudocysts. A rare cause of obstructive jaundice is Mirizzi’s syndrome.

The presence of pale stools and dark urine suggests an obstructive or post-hepatic cause as normal feces get their color from bile pigments.

Patients also can present with elevated serum cholesterol, and often complain of severe itching or “pruritus”.

Laboratory Tests
No one test can differentiate between various classifications of jaundice. A combinations of liver function tests is essential to arrive at a diagnosis.

Neonatal jaundice(jaundice in newborn infants)
Neonatal jaundice is usually harmless: this condition is often seen in infants around the second day after birth, lasting until day 8 in normal births, or to around day 14 in premature births. Serum bilirubin normally drops to a low level without any intervention required: the jaundice is presumably a consequence of metabolic and physiological adjustments after birth. In extreme cases, a brain-damaging condition known as kernicterus can occur; there are concerns that this condition has been rising in recent years due to inadequate detection and treatment of neonatal hyperbilirubinemia. Neonatal jaundice is a risk factor for hearing loss.

Click to see as per Ayurveda-> Yellow Jaundice, Newborn Jaundice, Causes & Symptoms

Jaundiced eye
It was once believed persons suffering from the medical condition jaundice saw everything as yellow. By extension, the jaundiced eye came to mean a prejudiced view, usually rather negative or critical. Alexander Pope, in ‘An Essay on Criticism’ (1711), wrote: “All seems infected that the infected spy, As all looks yellow to the jaundiced eye.” Similarly in the mid 19th century the English poet Lord Alfred Tennyson wrote in the poem ‘Locksley Hall’: “So I triumphe’d ere my passion sweeping thro’ me left me dry, left me with the palsied heart, and left me with a jaundiced eye.”

Problems Jaundice Cause :

Jaundice or cholestasis, by themselves, causes few problems (except in the newborn, and jaundice in the newborn is different than most other types of jaundice, as discussed later.) Jaundice can turn the skin and sclerae yellow. In addition, stool can become light in color, even clay-colored because of the absence of bilirubin that normally gives stool its brown color. The urine may turn dark or brownish in color. This occurs when the bilirubin that is building up in the blood begins to be excreted from the body in the urine. Just as in feces, the bilirubin turns the urine brown.

Besides the cosmetic issues of looking yellow and having dark urine and light stools, the symptom that is associated most frequently associated with jaundice or cholestasis is itching, medically known as pruritus. The itching associated with jaundice and cholestasis can sometimes be so severe that it causes patients to scratch their skin “raw,” have trouble sleeping, and, rarely, even to commit suicide.

It is the disease causing the jaundice that causes most problems associated with jaundice. Specifically, if the jaundice is due to liver disease, the patient may have symptoms or signs of liver disease or cirrhosis. (Cirrhosis represents advanced liver disease.) The symptoms and signs of liver disease and cirrhosis include fatigue, swelling of the ankles, muscle wasting, ascites (fluid accumulation in the abdominal cavity), mental confusion or coma, and bleeding into the intestines.

If the jaundice is caused by blockage of the bile ducts, no bile enters the intestine. Bile is necessary for digesting fat in the intestine and releasing vitamins from within it so that the vitamins can be absorbed into the body. Therefore, blockage of the flow of bile can lead to deficiencies of certain vitamins. For example, there may be a deficiency of vitamin K that prevents proteins that are needed for normal clotting of blood to be made by the liver, and, as a result, uncontrolled bleeding may occur.

Diseases cause jaundice:-
Increased production of bilirubin
There are several uncommon conditions that give rise to over-production of bilirubin. The bilirubin in the blood in these conditions usually is only mildly elevated, and the resultant jaundice usually is mild and difficult to detect. These conditions include: 1) rapid destruction of red blood cells (referred to as hemolysis), 2) a defect in the formation of red blood cells that leads to the over-production of hemoglobin in the bone marrow (called ineffective erythropoiesis), or 3) absorption of large amounts of hemoglobin when there has been much bleeding into tissues (e.g., from hematomas, collections of blood in the tissues).

Acute inflammation of the liver
Any condition in which the liver becomes inflamed can reduce the ability of the liver to conjugate (attach glucuronic acid to) and secrete bilirubin. Common examples include acute viral hepatitis, alcoholic hepatitis, and Tylenol-induced liver toxicity.

Chronic liver diseases
Chronic inflammation of the liver can lead to scarring and cirrhosis, and can ultimately result in jaundice. Common examples include chronic hepatitis B and C, alcoholic liver disease with cirrhosis, and autoimmune hepatitis.

Infiltrative diseases of the liver
Infiltrative diseases of the liver refer to diseases in which the liver is filled with cells or substances that don’t belong there. The most common example would be metastatic cancer to the liver, usually from cancers within the abdomen. Uncommon causes include a few diseases in which substances accumulate within the liver cells, for example, iron (hemochromatosis), alpha-one antitrypsin (alpha-one antitrypsin deficiency), and copper (Wilson’s disease).

Inflammation of the bile ducts
Diseases causing inflammation of the bile ducts, for example, primary biliary cirrhosis or sclerosing cholangitis and some drugs, can stop the flow of bile and elimination of bilirubin and lead to jaundice.

Blockage of the bile ducts
The most common causes of blockage of the bile ducts are gallstones and pancreatic cancer. Less common causes include cancers of the liver and bile ducts.

Drugs:-
Many drugs can cause jaundice and/or cholestasis. Some drugs can cause liver inflammation (hepatitis) similar to viral hepatitis. Other drugs can cause inflammation of the bile ducts, resulting in cholestasis and/or jaundice. Drugs also may interfere directly with the chemical processes within the cells of the liver and bile ducts that are responsible for the formation and secretion of bile to the intestine. As a result, the constituents of bile, including bilirubin, are retained in the body. The best example of a drug that causes this latter type of cholestasis and jaundice is estrogen. The primary treatment for jaundice caused by drugs is discontinuation of the drug. Almost always the bilirubin levels will return to normal within a few weeks, though in a few cases it may take several months.

Genetic disorders:-
There are several rare genetic disorders present from birth that give rise to jaundice. Crigler-Najjar syndrome is caused by a defect in the conjugation of bilirubin in the liver due to a reduction or absence of the enzyme responsible for conjugating the glucuronic acid to bilirubin. Dubin-Johnson and Rotor’s syndromes are caused by abnormal secretion of bilirubin into bile.

The only common genetic disorder that may cause jaundice is Gilbert’s syndrome which affects approximately 7% of the population. Gilbert’s syndrome is caused by a mild reduction in the activity of the enzyme responsible for conjugating the glucuronic acid to bilirubin. The increase in bilirubin in the blood usually is mild and infrequently reaches levels that cause jaundice. Gilbert’s syndrome is a benign condition that does not cause health problems.

Developmental abnormalities of bile ducts:-
There are rare instances in which the bile ducts do not develop normally and the flow of bile is interrupted. Jaundice frequently occurs. These diseases usually are present from birth though some of them may first be recognized in childhood or even adulthood. Cysts of the bile duct (choledochal cysts) are an example of such a developmental abnormality. Another example is Caroli’s disease.

Jaundice of pregnancy :-

Most of the diseases discussed previously can affect women during pregnancy, but there are some additional causes of jaundice that are unique to pregnancy.

Cholestasis of pregnancy. Cholestasis of pregnancy is an uncommon condition that occurs in pregnant women during the third trimester. The cholestasis is often accompanied by itching but infrequently causes jaundice. The itching can be severe, but there is treatment (ursodeoxycholic acid or ursodiol). Pregnant women with cholestasis usually do well although they may be at greater risk for developing gallstones. More importantly, there appears to be an increased risk to the fetus for developmental abnormalities. Cholestasis of pregnancy is more common in certain groups, particularly in Scandinavia and Chile, and tends to occur with each additional pregnancy. There also is an association between cholestasis of pregnancy and cholestasis caused by oral estrogens, and it has been hypothesized that it is the increased estrogens during pregnancy that are responsible for the cholestasis of pregnancy.

Pre-eclampsia. Pre-eclampsia, previously called toxemia of pregnancy, is a disease that occurs during the second half of pregnancy and involves several systems within the body, including the liver. It may result in high blood pressure, fluid retention, and damage to the kidneys as well as anemia and reduced numbers of platelets due to destruction of red blood cells and platelets. It often causes problems for the fetus. Although the bilirubin level in the blood is elevated in pre-eclampsia, it usually is mildly elevated, and jaundice is uncommon. Treatment of pre-eclampsia usually involves delivery of the fetus as soon as possible if the fetus is mature.

Acute fatty liver of pregnancy. Acute fatty liver of pregnancy (AFLP) is a very serious complication of pregnancy of unclear cause that often is associated with pre-eclampsia. It occurs late in pregnancy and results in failure of the liver. It can almost always be reversed by immediate delivery of the fetus. There is an increased risk of infant death. Jaundice is common, but not always present in AFLP. Treatment usually involves delivery of the fetus as soon as possible.

Diagnosis:-
Many tests are available for determining the cause of jaundice, but the history and physical examination are important as well.

History
The history can suggest possible reasons for the jaundice. For example, heavy use of alcohol suggests alcoholic liver disease, whereas use of illegal, injectable drugs suggests viral hepatitis. Recent initiation of a new drug suggests drug-induced jaundice. Episodes of abdominal pain associated with jaundice suggests blockage of the bile ducts usually by gallstones.

Physical examination
The most important part of the physical examination in a patient who is jaundiced is examination of the abdomen. Masses (tumors) in the abdomen suggest cancer infiltrating the liver (metastatic cancer) as the cause of the jaundice. An enlarged, firm liver suggests cirrhosis. A rock-hard, nodular liver suggests cancer within the liver.

Blood tests
Measurement of bilirubin can be helpful in determining the causes of jaundice. Markedly greater elevations of unconjugated bilirubin relative to elevations of conjugated bilirubin in the blood suggest hemolysis (destruction of red blood cells). Marked elevations of liver tests (aspartate amino transferase or AST and alanine amino transferase or ALT) suggest inflammation of the liver (such as viral hepatitis). Elevations of other liver tests, e.g., alkaline phosphatase, suggest diseases or obstruction of the bile ducts.

Ultrasonography
Ultrasonography is a simple, safe, and readily-available test that uses sound waves to examine the organs within the abdomen. Ultrasound examination of the abdomen may disclose gallstones, tumors in the liver or the pancreas, and dilated bile ducts due to obstruction (by gallstones or tumor).

Computerized tomography (CT or CAT scans)
Computerized tomography or CT scans are scans that use x-rays to examine the soft tissues of the abdomen. They are particularly good for identifying tumors in the liver and the pancreas and dilated bile ducts, though they are not as good as ultrasonography for identifying gallstones.

Magnetic resonance imaging (MRI)
Magnetic Resonance Imaging scans are scans that utilize magnetization of the body to examine the soft tissues of the abdomen. Like CT scans, they are good for identifying tumors and studying bile ducts. MRI scans can be modified to visualize the bile ducts better than CT scans (a procedure referred to as MR cholangiography), and, therefore, are better than CT for identifying the cause and location of bile duct obstruction.

Endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound
Endoscopic retrograde cholangiopancreatography (ERCP) provides the best means for examining the bile duct. For ERCP an endoscope is swallowed by the patient after he or she has been sedated. The endoscope is a flexible, fiberoptic tube approximately four feet in length with a light and camera on its tip. The tip of the endoscope is passed down the esophagus, through the stomach, and into the duodenum where the main bile duct enters the intestine. A thin tube then is passed through the endoscope and into the bile duct, and the duct is filled with x-ray contrast solution. An x-ray is taken that clearly demonstrates the contrast-filled bile ducts. ERCP is particularly good at demonstrating the cause and location of obstruction within the bile ducts. A major advantage of ERCP is that diagnostic and therapeutic procedures can be done at the same time as the x-rays. For example, if gallstones are found in the bile ducts, they can be removed. Stents can be placed in the bile ducts to relieve the obstruction caused by scarring or tumors. Biopsies of tumors can be obtained.

Ultrasonography can be combined with ERCP by using a specialized endoscope capable of doing ultrasound scanning. Endoscopic ultrasound is excellent for diagnosing small gallstones in the gallbladder and bile ducts that can be missed by other diagnostic methods such as ultrasound, CT, and MRI. It also is the best means of examining the pancreas for tumors and can facilitate biopsy through the endoscope of tumors within the pancreas.

Liver biopsy
Biopsy of the liver provides a small piece of tissue from the liver for examination under the microscope. The biopsy most commonly is done with a long needle after local injection of the skin of the abdomen overlying the liver with anesthetic. The needle passes through the skin and into the liver, cutting off a small piece of liver tissue. When the needle is withdrawn, the piece of liver comes with it. Liver biopsy is particularly good for diagnosing inflammation of the liver and bile ducts, cirrhosis, cancer, and fatty liver.

.

Treatment:

A doctor uses laboratory tests and imaging studies to determine the cause of the jaundice. If the problem is a disease of the liver, such as acute viral hepatitis, the jaundice usually disappears gradually as the condition of the liver improves. If the problem is blockage of a bile duct, surgery or surgical endoscopy (using a flexible viewing tube with surgical instruments attached: Endoscopy) is usually performed as soon as possible to reopen the affected bile duct. Itching caused by jaundice can be treated with cholestyramine Some Trade Names QUESTRAN taken by mouth. Usually, the itching gradually disappears as the liver’s condition improves.

With the exception of the treatments for specific causes of jaundice mentioned previously, the treatment of jaundice usually requires a diagnosis of the specific cause of the jaundice and treatment directed at the specific cause, e.g., removal of a gallstone blocking the bile duct.

You may click to see:->Natural & Herbal Remedies of Jaundice

Liver Care – Dietary And Ayurvedic Treatment, Home Remedies

Jaundice Treatment With Ayurvedic and Home Remedies

Herbal Supliment of Jaundice

Homeopathic Treatment for LIVER DISEASES Liver Enlargement, Hypertrophy, Jaundice, Hepatitis

HOMEOPATHY FOR JAUNDICE

Homeopathic jaundice remedies

Disclaimer: This information is not meant to be a substitute for professional medical advise or help. It is always best to consult with a Physician about serious health concerns. This information is in no way intended to diagnose or prescribe remedies.This is purely for educational purpose.

Resources:
http://en.wikipedia.org/wiki/Jaundice
http://www.medicinenet.com/jaundice/page2.htm
http://merck.com/mmhe/au/sec10/ch135/ch135b.html

Enhanced by Zemanta
Categories
News on Health & Science

A Viral Illness That Can Be Silent and Hard to Treat but Also Cured

Hepatitis C can take decades to show up as damage to the liver.

CLICK & SEE

Chronic viral hepatitis is now the leading reason for liver transplants.

Current combination therapy can be individualized to cure chronic infections in 40 to 80 percent of cases.

The consequences of being infected with hepatitis C can take years to appear. So while new cases of the disease have fallen sharply over the past few decades, many people infected years ago are only beginning to learn they carry the virus, and to grapple with its potentially serious effects.

For many, there is good news. Half of all chronic infections can now be cured through a therapy using a combination of drugs. But hepatitis C remains a wily virus, often lying low for years and then following a course so unpredictable that doctors sometimes aren’t sure whether to recommend treatment or advise patients to watch and wait.

The biggest obstacle to effective treatment remains the fact that a majority of the estimated 3.2 million Americans who harbor chronic hepatitis C aren’t even aware they have it. In four out of five people, there are no symptoms when the infection first occurs.

“Most of the people we see discovered they have chronic hepatitis C when they went to donate blood or had a physical exam in order to get insurance,” said Dr. Bruce R. Bacon, director of the division of gastroenterology and hepatology at Saint Louis University School of Medicine.

Almost a third of those exposed to hepatitis C recover fully; their immune systems rout the virus and eliminate it. About 70 percent develop chronic infections, which carry a significant risk of cirrhosis, or scarring, of the liver and liver cancer. Paradoxically, people who become sickest soon after being infected are most likely to fight off the virus, whereas those who have few if any initial symptoms are at greatest danger of suffering persistent infection.

The treatment currently recommended for chronic hepatitis C combines ribavirin, an antiviral drug, with interferon, a substance that increases the immune system’s virus-killing power. The treatment offers a lifelong cure for more than half of patients. But because the drugs are expensive and can have serious side effects, and because the course of disease varies so much from person to person, the decision to start therapy poses tough questions.

“About one-third of people with chronic hepatitis will go on to develop cirrhosis of the liver,” said Dr. Jay H. Hoofnagle, director of the Liver Disease Research Branch at the National Institutes of Health. “Only 5 to 10 percent will develop liver cancer. In other words, many people can live perfectly well with chronic hepatitis infection and never have any problems. The trouble is we can’t tell who will do well and who will die of the disease.”

Nor can doctors predict with certainty how patients will respond to the combination therapy. In 25 to 30 percent of patients, interferon produces anxiety and depression, sometimes so extreme that sufferers have attempted suicide. It can also cause debilitating flu-like symptoms.

“I can usually get anyone through two or three months of interferon and ribavirin. Beyond that, it gets really tough,” Dr. Hoofnagle said. “At least 10 percent of patients can’t make it through the recommended course of therapy.”

Fortunately, physicians are getting better at optimizing the benefits and controlling some of the unwanted side effects, thanks in part to new insights into the virus. Researchers have discovered that hepatitis C occurs in at least six forms, called genotypes. Genotype 1 is the most common and also the hardest to treat, requiring 48 weeks of treatment. Only about 40 percent of people with this subtype get rid of the virus. Genotypes 2 and 3 can be successfully treated in just 24 weeks, eliminating the virus in about 80 percent of cases.

The more rapidly virus levels begin to fall in patients, the better the odds of a cure. By monitoring levels of the virus in blood, some doctors say, it’s now possible to individualize the course of treatment.

“I call it the accordion effect,” said Dr. Ira Jacobsen, chief of the division of gastroenterology and hepatology at Weill Cornell Medical College in New York. “If virus levels drop off very quickly, we can shorten the course of therapy. If the response is slow, we can lengthen it, sometimes to as much as 72 weeks, and improve the chances of success.”

Shortening the course of therapy remains controversial because of the risk of relapse after the treatment is stopped. Relapse occurs when lingering viruses not eradicated by the medication multiply and surge back.

Antidepressant drugs, meanwhile, are being employed to ease psychiatric side effects. And doctors are getting better at predicting who will suffer depression after starting interferon.

“Not surprisingly, people with a history of depression are at greater risk,” said Dr. Francis Lotrich, assistant professor of psychiatry at the University of Pittsburgh. He and his colleagues have also observed that people with chronic sleep problems are also more likely to have trouble with depression. The reason is not clear, but studies are under way to see if improving people’s sleep with the use of insomnia medication or other techniques can lower the risk of psychiatric side effects.

The best medicine is prevention, and it’s here that the biggest gains have been won against hepatitis C. The number of new infections per year in the United States has plummeted from 240,000 in the 1980s to about 19,000 in 2006. Experts credit a screening test that now prevents hepatitis C from spreading via blood transfusions and organ transplantation, as well as public health messages aimed at discouraging the use of shared needles, which is the leading route of transmission.

In the absence of an effective vaccine, such messages, backed up by intensified surveillance, will remain the chief defense against this virus. In 2003, chronic hepatitis B and C became notifiable diseases that must be reported to federal health officials, enabling them to track new cases nationwide. In 2004, New York State began its own enhanced viral hepatitis surveillance network.

Two years ago, the program demonstrated its usefulness when officials in the Erie County Department of Health detected a cluster of cases centered in one zip code in suburban Buffalo.

“All we had at first was a bunch of dots on a map,” said Dr. Anthony J. Billittier IV, the Erie County health commissioner. Investigators went into the community and identified about 20 young people who were injecting drugs and sometimes sharing needles. The county responded by intensifying prevention efforts, including a free needle exchange.

“We’ve made a lot of progress against hepatitis C, but there’s still a lot to do,” Dr. Billittier said. “One one thing we know about this virus is it’s not going away.”

Sources: The New York Times

Reblog this post [with Zemanta]
Categories
Ailmemts & Remedies

Hepatitis B

Hepatitis B virus surface antigen. Transmission electron Micrograph

Image via Wikipedia

Definition:
Hepatitis B is the most common serious liver infection in the world. It is thought to be the leading cause of liver cancer.The World Health Organization estimates that hepatitis B infections lead to more than one million deaths every year.

CLICK & SEE

Virus classification:-
Group: Group VII (dsDNA-RT)
Family: Hepadnaviridae
Genus: Orthohepadnavirus
Species: Hepatitis B virus

Hepatitis B virus infects the liver of hominoidae, including humans, and causes an inflammation called hepatitis. It is a DNA virus and one of many unrelated viruses that cause viral hepatitis. The disease was originally known as “serum hepatitis” and has caused epidemics in parts of Asia and Africa. Hepatitis B is endemic in China and various other parts of Asia. The proportion of the world’s population currently infected with the virus is estimated at 3 to 6%, but up to a third have been exposed. Symptoms of the acute illness caused by the virus include liver inflammation, vomiting, jaundice, and rarely, death. Chronic hepatitis B may eventually cause liver cirrhosis and liver cancer, a fatal disease with very poor response to current chemotherapy. The infection is preventable by vaccination.

Symptoms:
The virus can cause a range of problems, including fever, fatigue, muscle or joint pain, loss of appetite, nausea and vomiting.

Chronic carriers have an increased risk of developing liver disease such as cirrhosis or liver cancer, because the hepatitis B virus steadily attacks the liver.

Chronic carriers will usually have on going inflammation of the liver and may eventually develop cirrhosis and liver cancer.

About 1% of people who are infected develop an extreme form of disease called acute fulminant hepatitis.

This condition can be fatal if not treated quickly. Sufferers may collapse with fatigue, have yellowing of the skin and eyes (jaundice) and develop swelling in their abdomen.

Hepatitis B virus infection may either be acute (self-limiting) or chronic (long-standing). Persons with self-limiting infection clear the infection spontaneously within weeks to months.

Children are less likely than adults to clear the infection. More than 95% of people who become infected as adults or older children will stage a full recovery and develop protective immunity to the virus. However, only 5% of newborns that acquire the infection from their mother at birth will clear the infection. Of those infected between the age of one to six, 70% will clear the infection.

Acute infection with hepatitis B virus is associated with acute viral hepatitis – an illness that begins with general ill-health, loss of appetite, nausea, vomiting, body aches, mild fever, dark urine, and then progresses to development of jaundice. It has been noted that itchy skin has been an indication as a possible symptom of all hepatitis virus types. The illness lasts for a few weeks and then gradually improves in most affected people. A few patients may have more severe liver disease (fulminant hepatic failure), and may die as a result of it. The infection may be entirely asymptomatic and may go unrecognized.

Chronic infection with Hepatitis B virus may be either asymptomatic or may be associated with a chronic inflammation of the liver (chronic hepatitis), leading to cirrhosis over a period of several years. This type of infection dramatically increases the incidence of hepatocellular carcinoma (liver cancer). Chronic carriers are encouraged to avoid consuming alcohol as it increases their risk for cirrhosis and liver cancer. Hepatitis B virus has been linked to the development of Membranous glomerulonephritis (MGN).

Hepatitis D infection can only occur with a concomitant infection with Hepatitis B virus because the Hepatitis D virus uses the Hepatitis B virus surface antigen to form a capsid. Co-infection with hepatitis D increases the risk of liver cirrhosis and liver cancer. Polyarteritis nodosa is more common in people with hepatitis B infection.

Causes:The disease is caused by the hepatitis B virus (HBV) that attacks the liver. The virus is transmitted through blood and bodily fluids that contain blood.This can occur through direct blood-to-blood contact, unprotected sex, and illicit drug use. It can also be passed from an infected woman to her new-born during the delivery process.

Risk Factor:It is thought that about one in three of the world’s population is infected by HBV.However, about 50% of those who carry the virus never develop any symptoms.
About nine out of ten people infected with HBV will eventually clear the virus from their bodies. But about 5-10% of infected adults will become chronic hepatitis B carriers, often without even knowing it.

Diagnosis:The tests, called assays, for detection of hepatitis B virus infection involve serum or blood tests that detect either viral antigens (proteins produced by the virus) or antibodies produced by the host. Interpretation of these assays is complex.

The hepatitis B surface antigen (HBsAg) is most frequently used to screen for the presence of this infection. It is the first detectable viral antigen to appear during infection. However, early in an infection, this antigen may not be present and it may be undetectable later in the infection as it is being cleared by the host. The infectious virion contains an inner “core particle” enclosing viral genome. The icosahedral core particle is made of 180 or 240 copies of core protein, alternatively known as hepatitis B core antigen, or HBcAg. During this ‘window’ in which the host remains infected but is successfully clearing the virus, IgM antibodies to the hepatitis B core antigen (anti-HBc IgM) may be the only serological evidence of disease.

Shortly after the appearance of the HBsAg, another antigen named as the hepatitis B e antigen (HBeAg) will appear. Traditionally, the presence of HBeAg in a host’s serum is associated with much higher rates of viral replication and enhanced infectivity; however, variants of the hepatitis B virus do not produce the ‘e’ antigen, so this rule does not always hold true. During the natural course of an infection, the HBeAg may be cleared, and antibodies to the ‘e’ antigen (anti-HBe) will arise immediately afterwards. This conversion is usually associated with a dramatic decline in viral replication.

If the host is able to clear the infection, eventually the HBsAg will become undetectable and will be followed by IgG antibodies to the hepatitis B surface antigen and core antigen, (anti-HBs and anti HBc IgG). A person negative for HBsAg but positive for anti-HBs has either cleared an infection or has been vaccinated previously.

Individuals who remain HBsAg positive for at least six months are considered to be hepatitis B carriers. Carriers of the virus may have chronic hepatitis B, which would be reflected by elevated serum alanine aminotransferase levels and inflammation of the liver, as revealed by biopsy. Carriers who have seroconverted to HBeAg negative status, particularly those who acquired the infection as adults, have very little viral multiplication and hence may be at little risk of long-term complications or of transmitting infection to others.

More recently, PCR tests have been developed to detect and measure the amount of viral nucleic acid in clinical specimens. These tests are called viral loads and are used to assess a person’s infection status and to monitor treatment.


Treatment:-
Acute hepatitis B infection does not usually require treatment because most adults clear the infection spontaneously. Early antiviral treatment may only be required in fewer than 1% of patients, whose infection takes a very aggressive course (“fulminant hepatitis”) or who are immunocompromised. On the other hand, treatment of chronic infection may be necessary to reduce the risk of cirrhosis and liver cancer. Chronically infected individuals with persistently elevated serum alanine aminotransferase, a marker of liver damage, and HBV DNA levels are candidates for therapy.

There are several drug treatments available to treat hepatitis B.Patients may be put on a four month course of injections of the drug interferon.

An alternative treatment is a drug called lamivudine which is taken orally once a day. Treatment is usually for one year. Sometimes lamivudine is combined with interferon.

Although none of the available drugs can clear the infection, they can stop the virus from replicating, and prevent liver damage such as cirrhosis and liver cancer. Treatments include antiviral drugs such as lamivudine, adefovir and entecavir, and immune system modulators such as interferon alpha. However, some individuals are much more likely to respond than others and this might be because of the genotype of the infecting virus or the patient’s heredity. The treatment works by reducing the viral load, (the amount of virus particles as measured in the blood), which in turn reduces viral replication in the liver.

On March 29, 2005, the US Food and Drug Administration (FDA) approved Entecavir for the treatment of Hepatitis B. On February 25, 2005, the EU Commission approved Peginterferon alfa-2a (Pegasys). On October 27, 2006, telbivudine gained FDA approval. It is marketed under the brand name Tyzeka in the US and Sebivo outside the US. It is approved in Switzerland.

Infants born to mothers known to carry hepatitis B can be treated with antibodies to the hepatitis B virus (hepatitis B immune globulin or HBIg). When given with the vaccine within twelve hours of birth, the risk of acquiring hepatitis B is reduced 95%. This treatment allows a mother to safely breastfeed her child.

Chronic patients may require a liver transplant…....CLICK & SEE

Prevention:It can be prevented by the use of a safe and effective vaccine.However, for the 400 million people world-wide who are already carriers of HBV, the vaccine is of no use.

Vaccination: Several vaccines have been developed for the prevention of hepatitis B virus infection. These rely on the use of one of the viral envelope proteins (hepatitis B surface antigen or HBsAg). The vaccine was originally prepared from plasma obtained from patients who had long-standing hepatitis B virus infection. However, currently, these are more often made using recombinant DNA technology, though plasma-derived vaccines continue to be used; the two types of vaccines are equally effective and safe.

Following vaccination Hepatitis B Surface antigen may be detected in serum for several days; this is known as vaccine antigenaemia .

Disclaimer: This information is not meant to be a substitute for professional medical advise or help. It is always best to consult with a Physician about serious health concerns. This information is in no way intended to diagnose or prescribe remedies.This is purely for educational purpose.
Resources:
http://news.bbc.co.uk/2/hi/health/1505615.stm
http://en.wikipedia.org/wiki/Hepatitis_B

Reblog this post [with Zemanta]
Categories
Herbs & Plants

Milk Thistle

[amazon_link asins=’B0013OULVA,B00EI46XSM,B003QB0QIQ,B000R2X33M,B01K20TYKY,B00TQ6TC80,B014ODUG6G,B01GQU9EZE,B002Y27K6O’ template=’ProductCarousel’ store=’finmeacur-20′ marketplace=’US’ link_id=’b9dd80e9-849e-11e7-9421-4712645abeef’]

Botanical Name: Silybum marianum
Family: N.O. Compositae,Asteraceae
Subfamily: Lactucoideae
Tribe: Cynareae
Genus: Silybum
Species: S. marianum
Kingdom: Plantae
Order: Asterales

Synonym-:Marian Thistle.  Carduus lactifolius. Carduus marianus. Centaurea dalmatica. Mariana lactea.
Common Names-:- Cardus marianus,  Milk thistle,  Blessed milkthistle,   Marian thistle, Mary thistle, Saint Mary‘s thistle, Mediterranean milk thistle, Variegated thistle and Scotch thistle,  Mary thistle, holy thistle. Milk thistle is sometimes called silymarin, which is actually a mixture of the herb’s active components, including silybinin (also called silibinin or silybin).

Latin Name-:-Silybum marianum

Habitat : Milk Thistle is native to  S. Europe, N. Africa and W. Asia. Naturalized in Britain.  It grows on  waste places, usually close to the sea, especially if the ground is dry and rocky.  .

Parts Used-: Whole herb, root, leaves, seeds and hull.

Description: Members of this genus grow as annual or biennial plants. The erect stem is tall, branched and furrowed but not spiny. The large, alternate leaves are waxy-lobed, toothed and thorny, as in other genera of thistle. The lower leaves are cauline (attached to the stem without petiole). The upper leaves have a clasping base. They have large, disc-shaped pink-to-purple, rarely white, solitary flower heads at the end of the stem. The flowers consist of tubular florets. The phyllaries under the flowers occur in many rows, with the outer row with spine-tipped lobes and apical spines. The fruit is a black achene with a white pappus

CLICK TO SEE THE PICTURES

Only two species are currently classified in this genus:

Silybum eburneum Coss. & Dur., known as the Silver Milk Thistle, Elephant Thistle, or Ivory Thistle
Silybum eburneum Coss. & Dur. var. hispanicum
Silybum marianum (L.) Gaertner, the Blessed Milk Thistle, which has a large number of other common names, such as Variegated Thistle.
The two species hybridise naturally, the hybrid being known as Silybum × gonzaloi Cantó , Sánchez Mata & Rivas Mart. (S. eburneum var. hispanicum x S. marianum)

A number of other plants have been classified in this genus in the past but have since been relocated elsewhere in the light of additional research.

S. marianum is by far the more widely known species. It is believed to give some remedy for liver diseases (e.g. viral hepatitis) and an extract, silymarin, is used in medicine. The adverse effect of the medicinal use of milk thistle is loose stools.

This handsome plant is not unworthy of a place in our gardens and shrubberies and was formerly frequently cultivated. The stalks, like those of most of our larger Thistles, may be eaten, and are palatable and nutritious. The leaves also may be eaten as a salad when young. Bryant, in his Flora Dietetica, writes of it: ‘The young shoots in the spring, cut close to the root with part of the stalk on, is one of the best boiling salads that is eaten, and surpasses the finest cabbage. They were sometimes baked in pies. The roots may be eaten like those of Salsify.’ In some districts the leaves are called ‘Pig Leaves,’ probably because pigs like them, and the seeds are a favourite food of goldfinches.

The common statement that this bird lines its nest with thistledown is scarcely accurate, the substance being in most cases the down of Colt’s-foot (Tussilago), or the cotton down from the willow, both of which are procurable at the building season, whereas thistledown is at that time immature.

Westmacott, writing in 1694, says of this Thistle: ‘It is a Friend to the Liver and Blood: the prickles cut off, they were formerly used to be boiled in the Spring and eaten with other herbs; but as the World decays, so doth the Use of good old things and others more delicate and less virtuous brought in.’

The heads of this Thistle formerly were eaten, boiled, treated like those of the Artichoke.

There is a tradition that the milk-white veins of the leaves originated in the milk of the Virgin which once fell upon a plant of Thistle, hence it was called Our Lady’s Thistle, and the Latin name of the species has the same derivation.
Cultivation:
Succeeds in any well-drained fertile garden soil. Prefers a calcareous soil and a sunny position. Hardy to about -15°c. The blessed thistle is a very ornamental plant that was formerly cultivated as a vegetable crop. Young plants are prone to damage from snails and slugs. Plants will often self sow freely.

Propagation:
Seed – if sown in situ during March or April, the plant will usually flower in the summer and complete its life cycle in one growing season. The seed can also be sown from May to August when the plant will normally wait until the following year to flower and thus behave as a biennial. The best edible roots should be produced from a May/June sowing, whilst sowing the seed in the spring as well as the summer should ensure a supply of edible leaves all year round.

Edible Uses :
Edible Parts: Flowers; Leaves; Oil; Oil; Root; Stem.
Edible Uses: Coffee; Oil; Oil.

Root – raw or cooked. A mild flavour and somewhat mucilaginous texture. When boiled, the roots resemble salsify (Tragopogon hispanicus). Leaves – raw or cooked. The very sharp leaf-spines must be removed first, which is quite a fiddly operation. The leaves are quite thick and have a mild flavour when young, at this time they are quite an acceptable ingredient of mixed salads, though they can become bitter in hot dry weather. When cooked they make an acceptable spinach substitute. It is possible to have leaves available all year round from successional sowings. Flower buds – cooked. A globe artichoke substitute, they are used before the flowers open. The flavour is mild and acceptable, but the buds are quite small and even more fiddly to use than globe artichokes. Stems – raw or cooked. They are best peeled and can be soaked to reduce the bitterness. Palatable and nutritious, they can be used like asparagus or rhubarb or added to salads. They are best used in spring when they are young. A good quality oil is obtained from the seeds. The roasted seed is a coffee substitute

HEALTH BENEFITS:

The seeds of this plant are used nowadays for the same purpose as Blessed Thistle, and on this point John Evelyn wrote: ‘Disarmed of its prickles and boiled, it is worthy of esteem, and thought to be a great breeder of milk and proper diet for women who are nurses.’

It is in popular use in Germany for curing jaundice and kindred biliary derangements. It also acts as a demulcent in catarrh and pleurisy. The decoction when applied externally is said to have proved beneficial in cases of cancer.

Gerard wrote of the Milk Thistle that:
‘the root if borne about one doth expel melancholy and remove all diseases connected therewith. . . . My opinion is that this is the best remedy that grows against all melancholy diseases,’
which was another way of saying that it had good action on the liver. He also tells us:
‘Dioscorides affirmed that the seeds being drunke are a remedy for infants that have their sinews drawn together, and for those that be bitten of serpents:’and we find in a record of old Saxon remedies that ‘this wort if hung upon a man’s neck it setteth snakes to flight.’ The seeds were also formerly thought to cure hydrophobia.
Culpepper considered the Milk Thistle to be as efficient as Carduus benedictus for agues, and preventing and curing the infection of the plague, and also for removal of obstructions of the liver and spleen. He recommends the infusion of the fresh root and seeds, not only as good against jaundice, also for breaking and expelling stone and being good for dropsy when taken internally, but in addition, to be applied externally, with cloths, to the liver. With other writers, he recommends the young, tender plant (after removing the prickles) to be boiled and eaten in the spring as a blood cleanser.
A tincture is prepared by homoeopathists for medicinal use from equal parts of the root and the seeds with the hull attached.

It is said that the empirical nostrum, antiglaireux, of Count Mattaei, is prepared from this species of Thistle.

Thistles in general, according to Culpepper, are under the dominion of Jupiter.
Milk thistles have been reported to have protective effects on the liver and to improve its function. They are typically used to treat liver cirrhosis, chronic hepatitis (liver inflammation), and gallbladder disorders. The active compound in Milk thistle credited with this effect is “silymarin”, and is typically administered in amount ranging from 200-500mg per day (common Milk Thistle supplements have an 80% standardized extract of silymarin). Increasing research is being carried out into its possible medical uses and the mechanisms of such effects. However, a previous literature review using only studies with both double-blind and placebo protocols concluded that milk thistle and its derivatives “does not seem to significantly influence the course of patients with alcoholic and/or hepatitis B or C liver diseases.”

Medicinal Uses:
Silymarin is poorly soluble in water, so aqueous preparations such as teas are ineffective, except for use as supportive treatment in gallbladder disorders because of cholagogic and spasmolytic effects. The drug is best administered parenterally because of poor absorption of silymarin from the gastrointestinal tract. The drug must be concentrated for oral use.   Silymarin’s hepatoprotective effects may be explained by its altering of the outer liver cell membrane structure, as to disallow entrance of toxins into the cell.  This alteration involves silymarin’s ability to block the toxin’s binding sites, thus hindering uptake by the cell.  Hepatoprotection by silymarin can also be attributed to its antioxidant properties by scavenging prooxidant free radicals and increasing intracellular concentration of glutathione, a substance required for detoxicating reactions in liver cells.

Silymarin’s mechanisms offer many types of therapeutic benefit in cirrhosis with the main benefit being hepatoprotection. Use of milk thistle, however, is inadvisable in decompensated cirrhosis.  In patients with acute viral hepatitis, silymarin shortened treatement time and showed improvement in serum levels of bilirubin, AST and ALT.

Treatment claims also include:

1.Lowering cholesterol levels
2.Reducing insulin resistance in people with type 2 diabetes who also have cirrhosis
3.Reducing the growth of cancer cells in breast, cervical, and prostate cancers.

4.Milk thistle is also used in many products claiming to reduce the effects of a hangover.

5.Milk thistle can also be found as an ingredient in some energy drinks like the AriZona Beverage Company Green Tea energy drink and Rockstar Energy Drink.


How It Is Used:

Milk thistle is a flowering herb. Silymarin, which can be extracted from the seeds (fruit), is believed to be the biologically active part of the herb. The seeds are used to prepare capsules containing powdered herb or seed; extracts; and infusions (strong teas).

What the Science Says:
There have been some studies of milk thistle on liver disease in humans, but these have been small. Some promising data have been reported, but study results at this time are mixed.
Although some studies conducted outside the United States support claims of oral milk thistle to improve liver function, there have been flaws in study design and reporting. To date, there is no conclusive evidence to prove its claimed uses.
NCCAM is supporting a phase II research study to better understand the use of milk thistle for chronic hepatitis C. With the National Institute of Diabetes and Digestive and Kidney Diseases, NCCAM is planning further studies of milk thistle for chronic hepatitis C and nonalcoholic steatohepatitis (liver disease that occurs in people who drink little or no alcohol).
The National Cancer Institute and the National Institute of Nursing Research are also studying milk thistle, for cancer prevention and to treat complications in HIV patients.

Other Uses:
Green manure; Oil; Oil..……A good green manure plant, producing a lot of bulk for incorporation into the soil.

Known Hazards  : When grown on nitrogen rich soils, especially those that have been fed with chemical fertilizers, this plant can concentrate nitrates in the leaves. Nitrates are implicated in stomach cancers. Diabetics should monitor blood glucose when using. Avoid if decompensated liver cirrhosis. Possible headaches, nausea, irritability and minor gastrointestinal upset

Disclaimer:
The information presented herein is intended for educational purposes only. Individual results may vary, and before using any supplements, it is always advisable to consult with your own health care provider
Resources:
http://en.wikipedia.org/wiki/Milk_Thistle
http://nccam.nih.gov/health/milkthistle/
http://botanical.com/botanical/mgmh/t/thistl11.html#mil

http://www.herbnet.com/Herb%20Uses_LMN.htm

Enhanced by Zemanta
css.php